“Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland”, Swiss Med Wkly, vol. 154, no. 10, p. 3958, Oct. 2024, doi: 10.57187/s.3958.